Evolva Holding SA Overview
Pro stress-test →Evolva Holding SA is a Swiss biotech company that uses synthetic biology and precision fermentation technology to discover and develop innovative, sustainable ingredients for health, nutrition, wellness, flavors, fragrances, and cosmetics. The company was founded in 2004 and built its reputation around proprietary technology enabling the creation of high-value compounds derived from yeast.
Strategic Profile
Pro stress-test →Evolva positioned itself as a synthetic biology innovator with a differentiated technological approach compared to traditional pharmaceutical chemistry. The company leveraged discovery partnerships with major players like Roche while developing its own pipeline of compounds including resveratrol, vanilla, pomecin, stevia, and saffron. In January 2024, the company's operating assets were acquired by Danstar Ferment AG (subsidiary of Lallemand Inc.), fundamentally transforming its strategic position.
Competitive Landscape
Pro stress-test →Evolva historically competed in the synthetic biology and precision fermentation space with companies in biotech, flavors/fragrances, and natural ingredients sectors. Major partnerships included Roche for drug discovery. Post-acquisition, the competitive landscape is largely irrelevant as Evolva is no longer an operating biotech company.
Industry Context
Evolva Holding SA operates in Biotech / Synthetic Biology (Historical); Non-Operating Holding Company (Current).
Key facts
Founded: 2001 · Headquarters: Reinach, Switzerland